These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9604126)

  • 1. The influence of food on the disposition of the antiepileptic rufinamide in healthy volunteers.
    Cardot JM; Lecaillon JB; Czendlik C; Godbillon J
    Biopharm Drug Dispos; 1998 May; 19(4):259-62. PubMed ID: 9604126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of food on the disposition of the antiepileptic oxcarbazepine and its major metabolites in healthy volunteers.
    Degen PH; Flesch G; Cardot JM; Czendlik C; Dieterle W
    Biopharm Drug Dispos; 1994 Aug; 15(6):519-26. PubMed ID: 7993989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and Tolerability of Rufinamide Following Single and Multiple Oral Doses and Effect of Food on Pharmacokinetics in Healthy Chinese Subjects.
    Xu M; Ni Y; Zhou Y; He X; Li H; Chen H; Li W
    Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):541-8. PubMed ID: 26294172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of food on the pharmacokinetics of multiple-dose oral voriconazole.
    Purkins L; Wood N; Kleinermans D; Greenhalgh K; Nichols D
    Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):17-23. PubMed ID: 14616409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of oral rufinamide in dogs.
    Wright HM; Chen AV; Martinez SE; Davies NM
    J Vet Pharmacol Ther; 2012 Dec; 35(6):529-33. PubMed ID: 22132708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, phase I, 3-way crossover study to examine the effects of food on the pharmacokinetics of single doses of 400 mg posaconazole oral suspension in healthy male Taiwanese subjects.
    Lin TY; Yang MH; Chang FY
    Ther Drug Monit; 2013 Apr; 35(2):223-7. PubMed ID: 23503449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Food Intake on the Relative Bioavailability of Amifampridine Phosphate Salt in Healthy Adults.
    Haroldsen PE; Musson DG; Hanson B; Quartel A; O'Neill CA
    Clin Ther; 2015 Jul; 37(7):1555-63. PubMed ID: 26101174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of food on the pharmacokinetics of a single oral dose of moxifloxacin 400mg in healthy male volunteers.
    Lettieri J; Vargas R; Agarwal V; Liu P
    Clin Pharmacokinet; 2001; 40 Suppl 1():19-25. PubMed ID: 11352438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of food on the disposition of the monoamine oxidase-A inhibitor brofaromine in healthy volunteers.
    Degen PH; Cardot JM; Czendlik C; Dieterle W
    Biopharm Drug Dispos; 1993 Apr; 14(3):209-15. PubMed ID: 8490109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone.
    Gandelman K; Lamson M; Salageanu J; Bramson C; Matschke K; Malhotra B
    Clin Pharmacol Drug Dev; 2015 Sep; 4(5):370-6. PubMed ID: 27137146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of food and sucralfate on a single oral dose of 500 milligrams of levofloxacin in healthy subjects.
    Lee LJ; Hafkin B; Lee ID; Hoh J; Dix R
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2196-200. PubMed ID: 9333047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Food increases the bioavailability of mefloquine.
    Crevoisier C; Handschin J; Barré J; Roumenov D; Kleinbloesem C
    Eur J Clin Pharmacol; 1997; 53(2):135-9. PubMed ID: 9403285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
    Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W
    Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of food on the absorption and pharmacokinetics of rivaroxaban.
    Stampfuss J; Kubitza D; Becka M; Mueck W
    Int J Clin Pharmacol Ther; 2013 Jul; 51(7):549-61. PubMed ID: 23458226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moexipril shows a long duration of action related to an extended pharmacokinetic half-life and prolonged ACE inhibition.
    Cawello W; Boekens H; Waitzinger J; Miller U
    Int J Clin Pharmacol Ther; 2002 Jan; 40(1):9-17. PubMed ID: 11837383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative bioavailability of letrozole under fed and fasting conditions in 12 healthy subjects after a 2.5 mg single oral administration.
    Sioufi A; Sandrenan N; Godbillon J; Trunet P; Czendlik C; Howald H; Pfister C; Ezzet F
    Biopharm Drug Dispos; 1997 Aug; 18(6):489-97. PubMed ID: 9267682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of three rufinamide oral suspensions compared with the marketed 400-mg tablet formulation: results from a randomized-sequence, open-label, four-period, four-sequence crossover study in healthy subjects.
    Critchley DJ; Aluri J; Boyd P; Whayman M; Narurkar M; Delargy H; Bibbiani F
    Clin Ther; 2011 Jan; 33(1):146-57. PubMed ID: 21397780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of food on the pharmacokinetics of a new multiple unit sustained release sodium valproate formulation.
    Retzow A; Vens-Cappell B; Wangemann M
    Arzneimittelforschung; 1997 Dec; 47(12):1347-50. PubMed ID: 9450162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.